Mphasis Limited (BOM:526299)
India flag India · Delayed Price · Currency is INR
2,436.90
+5.95 (0.24%)
At close: Nov 17, 2026
← View all transcripts

Q2 26/27

Nov 6, 2026

Summary

Q2 produced the strongest sequential growth in three years, a record pipeline and $466 million in net new TCV. FY 2027 revenue guidance rose to low double digits, while margins remain targeted at 14.75%-15.75%.

Operator

Good morning, ladies and gentlemen, and thanks for joining the Mphasis Q2 FY 2027 earnings conference call. I am Nirav, your moderator for the day. We have with us today Mr. Nitin Rakesh, CEO of Mphasis, Mr. Aravind Viswanathan, CFO, and Mr. Vinay Kalingara, Head of Investor Relations. As a reminder, there is a webcast link in the call invite mail that the Mphasis management team will be referring to today. The same presentation is also available on the Mphasis website, www.mphasis.com, in the Investor section under Financial & Filing, as well as on both BSE and NSE websites. Request you to have the presentation handy. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touch-tone phone. Please note that this conference is being recorded. Before we begin, I would like to state that some of the statements made in today's discussion may be forward-looking in nature and may involve risk and uncertainties. A detailed statement in this regard is available in the Q2 results release that was sent out to all of you earlier. I now hand over the floor to Mr. Nitin to begin with the proceeding of this call. Thank you, and over to you, Nitin.

Nitin Rakesh
CEO, Mphasis

Thank you, Nirav, and thank you all for joining us today. Q2 delivered what we said it would, our strongest sequential growth in three years, broad-based across verticals and segments. Our pipeline is at a record, and today we are raising our growth guidance for the year. I will take you through the numbers, but first, the thesis behind them. At our analyst meet in May, we said that the value in enterprise AI is moving from adoption to economic outcomes. AI is not only changing how services are delivered, it is changing what enterprises buy. Agentic AI asks what systems can do. Enterprise agency asks what an enterprise can now do better. We built Mphasis Tria to close what we call the agency gap, the distance between having AI and having AI make governed decisions that move revenue, margin, and risk. Five months on, we see three things.

First, the buyer has changed. Business and operations leaders now fund AI alongside the CIO, and their questions are about revenue leakage, planning latency, slow execution, and not just technology cost. That is where Mphasis Modernize and Mphasis Optimize meet them, and where outcome-linked commercial constructs follow. Second, Tria works as a closed loop. Understand, decide, act, measure, and improve, with humans governing the exceptions rather than signing off routine work. Every governed decision feeds back into the models, so enterprise context compounds. Third, the moat is not the models. Frontier models will continue to improve and commoditize. Our enduring differentiation lies in understanding enterprise context, causal decision intelligence, orchestration and governance, and the organizational capability to continuously learn, deploy, and scale these capabilities across our client enterprises. Independent research points the same way.

ISG September report, the AI value gap, found that AI is widely used, but outcomes lag, that nearly half of AI budgets now sit outside IT, and that model cost is only about a third of total investment. We welcome the collaboration, but we did not need it to set our course. It is the course we have been on since May and is now visible in our results. What I want to spend time on today is not only what we believe, but how we have organized to deliver it. Last quarter, we said Mphasis Tria was off to a stronger start than anticipated. In Q2, that early traction began to scale. Tria is now a proof point in large deal evaluations because it demonstrates governed measurable outcomes, not just capability. It is taking us into the operating core of the enterprise, the run of the business, not just the technology estate.

In BFS, it is opening business process budgets in lending origination, payment exception processing, and client onboarding as examples. Beyond BFS, it is driving conversations on AI-led operations transformation at large insurers, on-demand intelligence for technology clients, and so on. These budgets sit with business and operations leaders, and this has significantly increased our total addressable market. You will want to know how big our pipeline with Tria is. We are not breaking that out today, so let me describe its shape. Tria-led opportunities are a growing part of our pipeline, and they are different in kind, larger and multi-year deals, combining optimization and transformation with ongoing operations, sponsored by business leaders, and increasingly starting with a proof of value on the client's own processes.

As each first deployment lands, it leaves reusable assets and foundations for expansion within that client. That brings me to what matters most, execution. We have organized our talent to turn this pipeline into scale delivery. Value streams. We have packaged the recurring business problems in banking, insurance, and healthcare, for example, into defined offers, each with a clear buyer, outcome measures, and reusable assets. Opportunities start from a vertically packaged offering. Forward-deployed and engineering solutions teams sit in one team alongside delivery, embedded within the client, working through four steps: bring the problem, compose the capabilities, prove it with evidence, and scale. A dedicated product and platform team institutionalize learnings through a continuous feedback loop, turning every deployment into reusable capabilities that accelerate the next.

We are investing in people to run this, certifying our client-facing technology leaders on the value stream playbooks and expanding deployment capacity through our FPE teams. Together, these give us a repeatable path from first conversion to scaled outcome, and that is why we are confident in the trajectory. Since the launch of Mphasis.ai three years ago, our pipeline has now grown 3x to its original size, and AI-led deals have grown from 12% of the pipeline to 71%. Net new TCV for Q2 was $466 million, and with net new TCV above $400 million for six consecutive quarters, we have established a higher baseline for deal closures. That baseline supported the growth we delivered in Q2 and underpins the confidence in the trajectory for the rest of FY 2027. Pipeline composition is broad-based across verticals and deal sizes. Total pipeline reached a new high, growing 4.4% sequentially and 23% year-over-year.

We continue to see a high share of proactively originated opportunities, shaped by our point of view of clients' businesses and our ability to identify and define opportunities before they become formal asks. Growth was broad-based, with the BFS pipeline up 4.1% and non-BFS pipeline up 4.8% sequentially. Opportunities below $20 million grew 35% YoY and 9% sequentially, reflecting the increase in shorter cycle deal activity we called out last quarter, which continues to play out. On a year-on-year basis, modernization and TAP, now aligned to our Tria product lines, recorded the strongest growth in the pipeline. Agile IT Ops and NextOps are also significant contributors to the overall pipeline, reflecting the deals in process modernization and business outcome budgets we described earlier. As I mentioned earlier, net new TCV for the quarter was $466 million, with trailing 12-month TCV at $1.8 billion.

66% of our TCV wins in Q2 were AI-led, up from 63% last quarter. We closed five large deals in Q2. One of them nicely illustrates the shift in how the outcome deals are being structured. A large broker-dealer selected Mphasis to scale its advisor administration business across front and middle office services. It is a large deal with a recurring revenue share model and significant expansion potential across the client's advisor network. Deal wins continue to convert to revenue at a consistent pace. As we said last quarter, the trend of short-cycle deals is holding, with TCV for deals below $20 million up 26% on a trailing 12-month basis. Meanwhile, the backlog we built over prior quarters and the steady TCV wins provide ongoing support to in-quarter and near-term revenue conversion as well.

Moving to our segment performance. In the direct business, we grew 3.5% sequentially and 11.3% year -over -year in constant currency terms. From a geographic perspective, Americas continued to be our primary growth engine. It grew 3.1% sequentially and 12.4% YoY in direct, driven by ramp-ups in large deal wins and contributions from new logos. Rest of the world delivered a strong growth of 16.4% sequentially and 23.5% year -over -year in constant currency terms. This was led by a growing participation in the GCC ecosystem with our global clients. EMEA declined 3.3% sequentially and 9% YoY. As we have explained before, we classify geographies by the origin of contract. This quarter's EMEA numbers reflect revenue from a globally structured engagement that was allocated across regions. The underlying health of the business there remains intact.

From a service line perspective, enterprise applications remains our core growth engine and contributed to 75.6% of our revenue. Direct revenue grew 3.7% sequentially in APPS and 14.4% YoY in constant currency terms, driven predominantly by AI-led modernization deals. BPO sustained its momentum, growing 6.6% sequentially and 18.7% YoY in direct on new deal wins and AI-led propositions. Tria-led process modernization has become a defining theme in business reimagination since launch, driving pipeline and wins across APPS and BPO. ITO declined 4.9% sequentially and 21.3% YoY. This mainly reflects transformation projects moving into a steady phase. These were integrated build-plus-run programs, and as the build components finish, the work moves into the run phase. This impact is also reflected in the others vertical.

Moving to performance by vertical. BFS direct grew 4.5% sequentially and 15% YoY in constant currency terms, with an eight-quarter CQGR of 3.8%. Growth continues to come from wallet share gains in existing accounts and new deal wins, reflecting our domain depth and the right to win in financial services. Insurance returned to sequential growth of 1.8% and grew 14.7% YoY in direct, supported by Tria-led optimization programs across underwriting claims and risk operations. Based on last quarter's recovery and new deal ramp-ups, TMT grew 10.9% sequentially and 14.5% YoY in direct. On a trailing 12-month basis, BFS, insurance, and TMT, the verticals we identified as growth drivers, have all delivered, showing that our strategic focus is translating into results. In direct, BFS, insurance, and TMT delivered 15%, 28%, and 12% growth respectively on a trailing 12-month basis.

Logistics and transportation declined 12% sequentially on a smaller base. It continues to feel some impact from ongoing geopolitical uncertainty. It is now a smaller unit for us, so small changes in revenue produce larger percentage swings. While the other segment declined 6.4% sequentially and grew 1.8% YoY, healthcare within that segment delivered healthy growth. On the back of recent deal wins, including a large deal win this quarter, we expect healthcare to emerge as a growth driver. Moving on to client metrics, they show growth across the portfolio. On a trailing 12-month basis, our top five clients grew 15.1% year -over -year, and our top 10 grew 13% year -over -year. Our 11-20 clients grew faster at 22.7% year -over -year. That reflects the investment we made to widen our account coverage from the top 10 to the next 20.

Sequentially, top five clients grew 4.1%, and clients ranked 6-10 grew 4.9%. This growth has been driven largely by strong in-account execution, winning new deals, and ramping them up. Our client buckets are aligned the same way. We added two clients in the $50 million plus bracket sequentially, three in the $20 million plus bracket YoY, and five in the $5 million plus bracket YoY. Three of them on a sequential basis as well. As new accounts scale, they keep feeding the upper tiers of the pyramid. Moving to our financial metrics performance, Q2 EBIT margin remained flat. EPS increased 14.6% sequentially to INR 29.4. Operating cash flow generation was $34 million after normalizing a $39.5 million of remittances initiated on 30 September and received in October. DSO for the quarter was 105 days after normalizing for the delayed remittances I just mentioned on the previous slide.

This is more of a quarterly aberration and is expected to get to double digits levels in Q3. In summary, in July, we said Q2 would deliver our best sequential CC growth in three years, and that it would be broad-based, and it did. Direct revenue grew 3.5% sequentially and 11.3% YoY. BFS grew 4.5% sequentially and 15% YoY, and TMT grew 10.9% sequentially. The Americas and rest of the world delivered strong sequential growth. Applications and BPO were driven by AI-led modernization and new deal wins. Top five clients grew 15.1% YoY, and 11-20 grew 22.7%, with additions across client brands, both sequentially and year on year. Pipeline is at a record, up 23% YoY, with 71% of the pipeline being AI-led, and it spans verticals, deal sizes, and archetypes.

TCV wins were $466 million for the quarter, 66% AI-led, including five large deals, taking trailing 12-month TCV to $1.8 billion. We delivered stable margins within our stated range. That performance and the visibility behind it is why we are raising our outlook. Let me now turn to how we see the rest of the year. The first half has set a strong foundation for FY 2027, and we expect the second half to carry this momentum forward. Four things give us that confidence: a record and broad-based pipeline, six consecutive quarters of net new TCV above $400 million, with the backlog converting to revenue, steady execution from signing to revenue, and an organization built to scale the work we are winning. On that basis, we are raising the FY 2027 guidance. We now expect revenue growth in the low double digits range for the full year.

Last quarter, our guidance was high single digit to low double digits. We are doing so despite an uncertain macro environment because it rests on results already delivered and on visibility we can see in the pipeline and the backlog. On profitability, we continue to expect stable margins within the target stated band of 14.75%-15.75%, while we invest in capabilities that drive the next phase of growth. We continue to target 80% conversion of net income to operating cash flow in FY 2027, further normalizing in FY 2028. With that, I will open the call for questions. Operator, over to you.

Operator

Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on their touchtone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. Participants, you may press star and one to ask a question. First question is from the line of Gaurav Rateria from Morgan Stanley. Please go ahead. Gaurav, may I request you to unmute your line and proceed with your question, please?

Gaurav Rateria
Analyst, Morgan Stanley

Hi, can you hear me?

Operator

Yes.

Nitin Rakesh
CEO, Mphasis

Yes, now we can. Go ahead.

Gaurav Rateria
Analyst, Morgan Stanley

Yeah, hi. Congrats on good revenue performance. I have three questions. My first question is on your confidence for upgrading the guidance in the current macro, and the reason I am asking is because your deal wins have been in that particular range. So within the same deal win range, why upgrade of guidance or giving more confidence on the second half? Is that conversion ratio improving versus the past? Is that giving you more confidence? My second question is on pipeline. Historically, we have seen within that pipeline has been a lead indicator for your deal win numbers to inch up. You started building on pipeline and deal win numbers eventually started to inch up with a lag.

Given that the pipeline is building up now, is it fair to say that some of that will start reflecting in step up in the deal win numbers over a period of next two or three quarters? The last question is that where are we in the investment cycle on the building these IPs and the archetype, these archetypes that we had talked about on Tria and other things? At some point in time, will that investment phase become your plateau out and will that lead to margin accretion for the company as a whole? Thank you.

Nitin Rakesh
CEO, Mphasis

Thanks, Gaurav. I think the upgrade question linked to TCV, let me take it in two different ways. As I mentioned in my script, the confidence is really coming from what we have in the backlog combined with the pipeline and the deal propensity. Of course, we have added some healthy revenue in quarter in Q2 that gives us a starting base from a run rate perspective. That is also reflected in the headcount addition, especially when you see the client metrics of top five, top 10, and next 10. I think all of those metrics are green. So there is a fair amount of that run rate confidence that is coming in. On the question around linking it to TCV, while the TCV has stayed in the $400 million range, I mean, this is still a little bit higher than what we have had in the last three or four quarters.

I think, as I mentioned in the commentary itself, it is not just the TCV that matters. The shape and nature of the TCV matters as well when it comes to short-term growth and revenue performance. As I mentioned, I think if you look at just the trailing 12 month, there is a 26% increase in small deal TCV. Even if you look at the pipeline, we have seen a disproportionate increase in the less than $20 million TCV in the pipeline at 35%, and the overall pipeline is up about 23%. So what is happening is a fair amount of work and priority from our clients is focused on three areas right now. First is all AI engineering work.

Almost every large enterprise is very rapidly focused on building the AI foundations, the AI harness, the AI infrastructure layer that will effectively enable them to adopt AI at scale, and that is leading to a fair amount of work in aligning and helping them design, build, deploy, and scale these harnesses and foundations. Tria plays a role there as well because in many cases, there is an opportunity for us to help them expand their thinking on what the foundation should look like. So that is the first bucket of work. There is a, again, corroborated by headcount addition and growth in applications and growth in top accounts. Not a phenomena that is happening across client segments, but definitely the more mature, the larger clients are spending a fair amount of time, effort, and money, and these are typically the short cycle deals.

To give you an example, a $10 million six-month deal has the same propensity as a $100 million five-year deal when it comes to revenue growth. Second thing that is in focus is a fair amount of, and it is kind of linked to the first one, is the whole investment that is going into hardening the cyber estate. Also fairly AI engineering-led because it is not just about adopting a new AI tool or AI platform, it is also about hardening the way that they deal with everything from detection to remediation and everything in between, from identity and access management, non-human identity, the Mythos, post-Mythos world. So there is a fair amount of engineering work that is going in there as well, and we have a very strong positioning with that, including the work we have done in the post-quantum cryptography side over the last few years.

That is starting to get monetized here as well. And the third thing that is driving the pipeline and the deal wins is what we used to call savings-led transformation, and I think Tria has really strengthened that thesis where the client is not just looking to save money, they are also looking to see how they can transform the way they run the business, both operations and IT. So there are very many themes of that. Vendor consolidation is a theme of that, right? But the outcome that the client is looking for is savings and transformation combined together. So that is kind of what is going on on the client side, and that is what is driving the pipeline and the TCV wins, but the shape of those TCV wins is what is driving the confidence in revenue, and you have seen that performance play out in the last two quarters.

Pipeline's definitely a lead indicator, as you mentioned, going to your second question. Of course, at some point, we see large deal conversion ramp up. Are we expecting TCV ramp up in the next two to four quarters? The short answer is yes, because we have to obviously keep the conversion rate as high it is or higher, and hence that will reflect into some of those deals converting. Large deals, by definition, are lumpy. You can't really put a finger on say, "This deal will close on this date." But as we continue to execute the pipeline, I think we expect that the TCV numbers will stay healthier or in check as well.

On the investment cycle for Tria and the IP buildup, I think it's too early to say that at what point will we mature, because the pace of change and the propensity of change is very, very fast. While we are not really focusing on trying to compete on the tool stack, we also have to make sure that everything we're doing from a Tria perspective across the layers doesn't really get commoditized, so we'll continue to invest at least for the near future. As we see ramp-ups happening on adoption of Tria, we'd called out some in the shape of what's going on. You can definitely expect them. I think the impact of enabling Tria-led delivery will definitely have a tailwind to margins more than just the investment we're making in Tria.

We are more focused on driving gross margin higher through adoption of Tria versus driving margin higher by choking investment in Tria.

Gaurav Rateria
Analyst, Morgan Stanley

All right. Thank you. All the best. I'll fall back in queue.

Nitin Rakesh
CEO, Mphasis

Thank you.

Operator

Thank you very much. Next question is from the line of Sandeep Shah from Equirus Securities. Please go ahead.

Sandeep Shah
Analyst, Equirus Securities

[Today time.]

Operator

Sandeep, sorry to interrupt you. You were not audible. Can you please repeat your question once again from the beginning?

Sandeep Shah
Analyst, Equirus Securities

Yeah. Am I audible now? Hello?

Operator

Nitin, sir, if you can confirm.

Nitin Rakesh
CEO, Mphasis

Yes, you are audible.

Sandeep Shah
Analyst, Equirus Securities

Hello?

Nitin Rakesh
CEO, Mphasis

Go ahead. Yes, go ahead.

Sandeep Shah
Analyst, Equirus Securities

Yeah. Congrats on a good set of numbers, despite difficult macro times. The first question you partly answered about press on the Tria. Just wanted to understand, can you give some color in terms of the revenue coming through Tria or outcome-based business model?

Nitin Rakesh
CEO, Mphasis

I think a little bit premature, Sandeep, to give you that metric. As we mentioned back in May that we will use FY 2027 as a foundational year to drive the right set of metrics. That's the reason I expanded on where we are seeing the uptick and where we are seeing the impact. So, definitely, the Tria-led opportunities are not just in the pipeline, they're also in the deal wins. We have our first set of deployments going live as we speak. Remember, we launched the platform in May. We've already got first set of deployments going live, so we will definitely have a really good, not just learnings, but more importantly, validation, set of validated deployments that we can then scale.

So, little bit premature to give you percentage of revenue or pipeline or TCV, but we'll evolve those metrics over the next two quarters and definitely create a list that we can share with you.

Sandeep Shah
Analyst, Equirus Securities

Okay. Just some bookkeeping question on the cash generation in this quarter. So, Aravind, if I look at to achieve the guidance of 80% OCF to PAT, the second half ask rate is very high, upwards of 100%-110%. Even if I adjust the $39.5 million collection, which got delayed from September to October. So what will drive this?

Aravind Viswanathan
CFO, Mphasis

Sandeep, if you look at it, there has been a little bit of our DSOs, even on a normalized basis, have gone up by about 10 days. If you look at it between Q1 and Q2. That is disappointing, and we are trying to get that back. As we move and get some of that back on trajectory, that is the basis for the improvement in cash flow for the coming quarters.

Sandeep Shah
Analyst, Equirus Securities

Okay. Aravind, if I look at last year, the payment for purchase consideration of acquired contracts has been INR 432 CR, while in this year first half, it has been at INR 143 CR. Your statement to normalize OCF to PAT in FY 2028, this could be a bigger contributor where this kind of a payment for contract acquisition consideration may come down materially next year versus this year?

Aravind Viswanathan
CFO, Mphasis

If you look at, that actually goes below OCF, if you are looking at the—

Sandeep Shah
Analyst, Equirus Securities

Yeah, sorry, OCF also.

Aravind Viswanathan
CFO, Mphasis

That really is. You are right. Having said that, you know, we have announced one on Red Oak, which we expect. The closing conditions are expected to be concluded in November, so that's a $28 million kind of commitment. To some extent, all of the deals in the table are visible to you. I do not think it will go up for sure, but there will be a little bit. It will be lower, but how much lower will be dependent on how many deals we do. Right now, at least, I think it's fair to assume that it will be lower in FY 2028 than in FY 2027.

Sandeep Shah
Analyst, Equirus Securities

Okay. The last question in terms of margin. Just last question in terms of margin. The first half margin is at the lower end of the comfort range. How do we see the second half of the margin in terms of full year guidance?

Aravind Viswanathan
CFO, Mphasis

I think our guidance range, beginning of the year, last year also has been 14.75%-15.75%. I am not really going to break down further within the range as to where we will be for H1 and H2. You are right that we are around 14.8%, and we have talked about some of the investments that have really pulled it down. If you look at it, we made an acquisition for Tria, with TAP, and that has certain amortization cost that has come in this year. We have seen a stronger growth momentum, especially in short cycle deals where there is a significant shift towards onsite, particularly with these AI programs where the initial portion of the business starts onsite. You have seen a big shift in onsite mix.

Some of those have put stretch on margins, and frankly, we will have to make those investments for growth. That is where we are. We remain committed to the guidance range, and I will leave it at that.

Nitin Rakesh
CEO, Mphasis

Yeah, Sandeep, I think just to put it in perspective.

Sandeep Shah
Analyst, Equirus Securities

Okay

Nitin Rakesh
CEO, Mphasis

I think, just when Gaurav asked me that question around what gives us the confidence to drive growth and upgrade the guidance, I think we are sitting at the intersection of some of these really interesting large enterprise programs. If we have to capture that wallet share, I think we are making sure that we have the ability to optimize and monetize every opportunity that we see on the table. If that means that we are not at the ideal midpoint of the margin range, I think we have more control on normalizing that than leaving revenue on the table. That's kind of the mindset while we continue to invest in building IP and investing in both coverage sales and platforms. I think all in all, we'll continue to prioritize growth.

Margins are something we can absolutely fix, because that's more of an optimization exercise that can happen internally, but growth is really what is client-dependent, and that's where our focus is.

Sandeep Shah
Analyst, Equirus Securities

Yeah, thanks. Got it. Fair enough. All the best.

Operator

Thank you.

Aravind Viswanathan
CFO, Mphasis

Thanks, Sandeep.

Operator

Next question is from the line of Vibhor Singhal from Nuvama. Please go ahead.

Vibhor Singhal
Analyst, Nuvama

Yeah, hi. Thanks for taking my question, and congrats on the solid performance yet again this time. So, there's a couple of questions from my side, mainly on the AI side and also two questions mainly on that part, and then one on the portfolio. If you look at, I think, commentary by various players, I think there are two very different kind of commentaries that we're hearing. One is the first, a lot of clients are focusing on consolidation, a lot of vendors are focusing on consolidation deals. But there have also been pockets in which vendors have mentioned that the new AI deals are kind of smaller in size and deal value, and they basically are kind of a get a foot in the door kind of deal to the client. And then once that deal gets sold, the client renews that deal and gives you more work.

But that basically impacts the overall TCV number in terms of the deal sizes. Are we also seeing that, these are our deals, and I mean, if that's the case, which kind of deals are we focusing on? Which do you think is going to drive the market going forward? The second question, again on the AI part is, we've seen the token cost come down almost 50%- 52% in the past six months. In your conversation with the clients, is that kind of helping vendors like us, as in it frees up the money that the client was kind of spending, as you mentioned, outside the IT budget? So it frees up that budget, and does that help us in any way? If not today, then tomorrow? Just your view on these two things.

Nitin Rakesh
CEO, Mphasis

Sure, Vibhor. Both are great questions. I think the way to think about AI-led deals is in two buckets. One I addressed when I answered to Gaurav as well earlier, that we are seeing an uptick in short cycle, short burst deals because there's a lot of AI engineering activity that's going on, whether it's around data mod, whether it's around building the harness, or cyber. That's one category of AI-led deals where you have the propensity to capture in-year budget, immediate spend patterns, because those are highly prioritized, time-sensitive programs. The other way to capture AI-led deals is essentially through a combination of what I call savings-led transformation, which is AI infused with operations. And those deals are not necessarily small deals. Vendor consolidation is one instantiation of those kind of deals.

Not every deal that we have that is AI-led, combination of both, is an RFP or a vendor consolidation deal, because there is new TAM we are opening up there as well. But there are deals here in our pipeline, there are vendor consolidation deals where the theme of AI-led transformation driving savings is very much alive as well. So, those are not necessarily small deals. The propensity and the ability to win those deals depends on three or four things. The ability to drive that kind of transformation with AI, number one. Number two, meeting the financial objectives that the client has set out. And number three, of course, there is an element of deal structuring and making sure that it works for both parties.

And of course, those kind of deals are highly competitive because everyone, especially the large players, are very happy to use their balance sheet to drive some of those deal restructuring cycles. We have to obviously be very, very cautious in how far we go. But when it comes to capability, when it comes to AI-led transformation with operations and IT, I think we are very much in the mix and will continue to drive pipeline and closures. On the second question around token cost, I think we predicted that token costs will continue to go down. I think they will go down even more. That absolutely releases some pressure from the enterprises on where their AI investment is going. But that's a different category than tapping into a new segment that our industry wasn't playing in earlier. The traditional BPO business had a very defined boundary around it.

With this kind of an approach where we are doing reimagining the business, we are able to penetrate things that were not traditionally seen as BPO-able. I think those are the two different buckets that we are seeing. Absolutely, your answer is right. Releasing of pressure on token costs, adopting these programs at scale, building some real smart intelligence and scientific way of managing what workload goes to which language model to optimize token costs, all of those things will become part of the harnesses I talked about. That's the phase we are in right now.

Vibhor Singhal
Analyst, Nuvama

Got it. Thank you so much for that, [sir]. Just one last question on the logistics vertical. How to look at this vertical hereafter? I mean, the vertical continues to decline even after the top line issue that we had seen last year. It's now less than 4% of our revenue. Historically, what we have seen earlier with DXC and later with the mortgage business, that once those businesses started declining, they never recovered, and then they became too small to become relevant in the larger scheme of things. Is that the way to look at logistics vertical also, that today it is less than 4% of revenue, maybe a few quarters down the line it becomes 2%-3%, and then we stop looking at it altogether in terms of any revival in this segment?

Nitin Rakesh
CEO, Mphasis

I would not compare the logistics trajectory to what happened with the other two units that you mentioned. I mean, mortgage business is still very much part of our overall value proposition in BFS. It is cyclical in nature. I don't think it's about structurally us disinvesting it from that business or moving away from saying that we will take this offering. I think the way to think about the logistics business is that we've seen some headwinds over the last five or six quarters. We've done a fair amount of effort, and we continue to do a fair amount of effort in rebuilding the foundations for that vertical. The nature of customers is still very much enterprise and top tier. We have some best brands in the business in that vertical already that we are working with across airlines, transportation, and logistics.

I think we have to do whatever it takes for us to continue to find pathway around expansion of wallet share. There are already clients where we are top two, top three providers. They're not quite at the scale where we think the potential is, so we may have a $20 million a year customer in that vertical that we think can go to $50, $60, $80, or $100 million as well. I think we are very much committed to that vertical. It's an execution and maturity phase that we are trying to drive out of that business. I would not compare them to us getting disinterested and it falling by the wayside. If anything, we are actually making even bigger investments in some of these accounts because our account motion that has worked very well across other verticals is working here as well.

Vibhor Singhal
Analyst, Nuvama

Got it. Great. Thank you so much for taking my questions and wish you all the best.

Operator

Thank you. Next question is from Dipesh Mehta from Emkay Global. Please go ahead.

Dipesh Mehta
Analyst, Emkay Global

Yeah. Thanks for the opportunity. Couple of questions. First about how many clients, let's say, might have adopted Mphasis Tria? You said revenue difficult, but can you give some sense about, let's say, how the client traction is playing out? Among our top 20, top 40, how many clients where we have already some inroad in adoption call? Second question is about the furlough. How do you expect furlough to play out in this year? Maybe if you can give relative comparison or absolute, whichever you can give some sense on. Third question is about the cybersecurity practice. Can you give some sense about size and scale of our cybersecurity practice and how it is growing in terms of revenue trajectory perspective? Last is about the short-term revenue deal. We are seeing significant improvement compared to earlier trajectory. How to interpret that from revenue conversion perspective?

Earlier, we used to give some correlation between revenue and TCV. Currently, we are seeing some shift in terms of the nature of deal. How one should expect revenue trajectory compared to TCV reported? If you can give some broad sense around that metric. Thanks.

Nitin Rakesh
CEO, Mphasis

I think on the first question, Dipesh, around how many clients have adopted Tria, I think it is too early for us to give you an exact number because, as I said, we are in phase where we have live deployments that are undergoing as we speak. But all I will tell you is that it is not just one client. It is a multiple number of customers, and they are across verticals. As we scale those from initial deployments to multiple different lines of businesses or replicate what we have built as foundation to additional businesses within the client, we will have a better idea of what the size potential and revenue shape will look like for Tria platform. I think be a little bit more patient. I do not think we are ready yet to share any metrics or numbers.

One, it is too premature, and two, I think there is work to be done in making sure that we are well established to drive that on a sustainable basis. I will let Aravind answer the question on furlough and short-term deals and the correlation that you asked me. But on the cyber practice, while it is not a very big We are not a very big cyber operations shop, but we definitely have a fair amount of work that we do in areas like identity and access management, as well as we have a cyber fusion center that we launched in our ODC two or three years ago that has become the foundation for us to do a lot of work there. But the real interesting work that we are doing in cyber really happens to be around the AI enablement of the entire cyber ops and vulnerability operation side.

I mentioned the post-quantum cryptography capability that we built that is now sitting right in the middle of that as well. So, it sits in our APPS business more than anything, because in the end, all the work we are really doing is around application remediation and IAM. It is a fast-growing business. I do not think we will break it out. We are not breaking out anything by service line outside of APPS, BPO, and ITO. As we reset some metrics for FY 2028, we may think about giving some additional color on it. But at this point, absolutely a fast-growing business driven primarily in the APPS bucket. Aravind, you want to maybe answer on the furlough and-

Aravind Viswanathan
CFO, Mphasis

So, Dipesh, on furlough, right now, nothing to call. I mean, historically, we have seen about 2% kind of impact at an organization level of furlough, right? That is really been what we have seen. Right now, as we stand here, no reason to believe it is going to be different this year, right? So, there is nothing to comment. Obviously, a lot of work happens on furlough mitigation and finalization in December, and fingers crossed, we will have to see how that plays out. As far as correlation of deal cycle is concerned, see, I think when there is a shift in terms of intensity on a TCV basis between long tenor and short tenor. You can do more growth with lesser absolute TCV, right?

In a way, it kind of takes correlation out of whack, because you would find that maybe last year we had much larger TCV in Q1, Q2 compared to this year, but our growth trajectory actually better this year than last year. That is because the TCV to ACV conversion changes, and that is really not factored in the correlation between TCV and revenue growth, which is why that metric kind of becomes a little off-key when there is such a sharp shift in the nature of TCV. I think you have seen an acceleration on revenue growth. Nitin talked about confidence for H2, which resulted in us upping the guidance, and that has happened without necessarily a big uplift in TCV, but consistent TCV growth of $400 million plus. That is really what has happened, Dipesh.

Dipesh Mehta
Analyst, Emkay Global

Thank you.

Operator

Dipesh, do you have any follow-up question?

Dipesh Mehta
Analyst, Emkay Global

No, thank you.

Operator

Thank you very much. Next question is from Prateek Maheshwari from HSBC Securities. Please go ahead.

Prateek Maheshwari
Analyst, HSBC Securities

Hi. Thank you for the opportunity. I have a follow-up question on the operating margins. I just wanted to understand, particularly for the deals that were savings-led transformation. Basically, I think that you guys have been ahead on these deals, right? My understanding was that these deals would have lower margins initially than your average, and improve as you apply in delivery and later turn the work more IP or platform-led, right? I just wanted to understand if you guys see that we are at a point in many of such ongoing deals which can soon provide a tailwind to margin expansion.

Nitin Rakesh
CEO, Mphasis

Yeah. Prateek, I think the thesis you're mentioning is the right thesis. That's the right way to think about it. The only caveat I will make to that is that this is likely to be a steady stream of deals of that nature. So, while we normalize and apply transformation and automation to a deal that we would have signed in Q1 or Q4, there is a pipeline of such deals that will continue to run through, and which will mean that we have continued We leave the ability to continue to apply that to the next set of deals. But as we accumulate a bunch of these deals and the platform gets deployed and matures in steady state, that's absolutely when the margin tailwind will start showing up.

Just to give you another data point that substantiates it, if there is a Tria-led or a platform-led savings or transformation deal, the sold margin shape is actually likely to be different than the traditional sold margin that we've seen in the previous year. So, that's kind of the way to think about it, but will it show up immediately in Q3 or Q4? It's hard to tell because we are still building pipeline and deals and deploying the platform.

Prateek Maheshwari
Analyst, HSBC Securities

Thanks, Nitin. Nitin, just one more question around the TCV. Just comparing your TCV explanation and also the guidance increase on the revenue, right? I think while the new deal wins are very similar to what was the average for the last four quarters, right? Is it the short cycle deal which will probably improve the revenue conversion, and so, overall, the deal wins are still better than even the average?

Nitin Rakesh
CEO, Mphasis

I think it's a combination. It's not just the short cycle deals that are converting better. It's even the, I think, the TCV sold even in the larger deals, while there was a period of time where conversion took time, especially at the end of middle of FY 2026 or late 2026. But at this point, the conversion seems to be pretty robust and nothing else to call out for in saying that there is a delay. Of course, decision cycles are not easy, especially for long-term deals, given the fair amount of complexity our clients are dealing with when it comes to making those decisions in the uncertainty of I mean, there's a fair amount of AI noise, and the speed of change also scares the customer from committing. But that aside, I don't think there's anything else to call out from a conversion to slow down.

If anything, that steady conversion rate has really helped us deliver the numbers that we've delivered.

Prateek Maheshwari
Analyst, HSBC Securities

Right. Aravind, just as these short cycle deals become more in the overall deal wins, I understand that in the larger deals, probably it had some of the larger investments on the cash side, right? As that mix changes, do you think that drives more confidence on the cash conversion later on?

Aravind Viswanathan
CFO, Mphasis

You are right? That's a fair point, right? You will not have any kind of concern. Having said that, I don't think in this year we've had any deals which has necessitated a big cash investment from our side. We've done $900 million plus of net new TCV in H1. I don't think any of those deals really had a material kind of cash flow investment. I think we did that in a meaningful way in FY 2026, and some of that impact is playing out in FY 2027. Which is why even from a commentary standpoint, we expect FY 2028 to go back to historic levels. So, the combination of both, pickup in the short cycle deals as well as the other large deals like what Nitin mentioned, where we didn't really have to make this kind of investment.

Prateek Maheshwari
Analyst, HSBC Securities

Okay. Thank you so much. Those are my questions. I'll put back in the queue.

Operator

Thank you. Next question is from Aditi Patil from ICICI Securities. Please go ahead.

Aditi Patil
Analyst, ICICI Securities

Thank you for the opportunity. The first question is on the. You mentioned about the large deal with a large broker, which also has a recurring revenue sharing model. So, how big or how large could be that revenue sharing component in the mature phase, and what could be the margin profile of this revenue sharing component? Will it be similar to the IP margin profile? Do you see more such outcome-based revenue sharing deals in your pipeline today? My second question is on the top client. We have seen a strong sequential and year-over-year growth in our top client. What has driven this growth, and do you expect the run rate to the top client to sustain? My last question is on the TMT vertical. For the last two quarters, we are seeing a good growth in this vertical.

Can you share the client subsegments we are serving within this vertical? Which kind of clients and what type of work we are doing is driving growth for us? Because several industry peers have flagged lower spend from tech clients as they prioritize AI CapEx. How durable is this growth, like outlook for the TMT vertical?

Nitin Rakesh
CEO, Mphasis

Thanks, Aditi. I think on the deal where the outcome-based deal where we talked about a revenue share, I don't think it is appropriate for me to share the details given competitive intensity. I think there is a certain effort that has gone into constructing a deal of that nature. A lot of our peers have talked about outcome-based deals, but they're really recasting output-based deals as outcome-based deals. So, let the model mature. As we have more examples to share, at some point, we will talk a little bit more about it, but it's a percentage of revenue share. In a way, this is an alignment to the growth initiative of the broker-dealer. This is not on the cost side.

The reason for that is that they felt that capacity constraint in servicing the broker-dealer network, especially middle and back office, without having a strong tech platform capability was what was constraining their growth. Hence, they have aligned incentives on both sides, and we worked hard at making sure that we have the ability to give them the scale, the speed, and the efficiency that they need in onboarding and servicing these new advisors on their network. So, it's an interesting deal. It's definitely one of the five large deals that we've announced in the quarter. It is on the larger side. So, we made some estimates on where we think we can end up with that over the next five years or so.

It definitely has the potential to be bigger than what we've estimated it to be, but right now, it's too early for us to call. We need to operationalize it. We already operationalized it. We need to kind of stabilize it and get to a rhythm and see if we can follow the growth pattern. As they grow, we grow. On top client, I think it's not fair to answer a client-specific outlook. We are very happy that we've grown top five, top 10, and next 10 clients very well, next 20, in fact. As I mentioned earlier, wherever we see opportunity, we have the ability to and the trust with those clients to be able to monetize those opportunities short term and long term.

Given that many of our top clients are sophisticated large buyers, I think I am very proud of the fact that the teams continue to become a very large provider and partner to those clients, and hence, we have seen that kind of execution show up consistently in the last few quarters in that segment. TMT is an interesting one. We know we have three or four subsegments in that. There is device makers. Given our heritage of ownership, we have a very strong footprint in R&D, as well as driving product engineering work there. We do a fair amount of work on the embedded software side. Second subsegment is high tech. Think of all the big tech names. That is a client segment. It was small. It is starting to grow. A lot of potential to grow. Our positioning there is not that of a scaled provider with rate cards.

We are trying to make sure that wherever we go in, we have the ability to differentiate and find our own capability and specialization. The third subsegment there is telecom. We have seen rapid expansion in that segment with some clients breaking into our top 10 client category, driven again by the fact that they see us as a refreshing transformation-led software engineering partner, versus many of the incumbents that they have been dealing with and the usual names that used to service their sector. I think the fourth segment there is still small, but we will continue to find ways to expand our book of business with the ISVs. So, I would say in that order, device makers, telecom, high-tech companies, and ISVs are the four subsegments in TMT, given the track record not just of the last two quarters, but of the last three years in that segment.

I think there is a significant opportunity for us to continue to make that bigger. It is already our second-biggest vertical after banking, close to insurance size, but very happy with the performance of that unit.

Aditi Patil
Analyst, ICICI Securities

Okay, got it. Thank you for answering my question.

Operator

Thank you. Next question is from Kumar Rakesh from BNP Paribas Mutual Fund. Please go ahead.

Kumar Rakesh
Analyst, BNP Paribas Mutual Fund

Hi, thank you for taking my question. My question was around the free cash flow during the quarter. So, usually, the visibility on free cash flow in a contractual business is much higher than that would be on revenue, especially when we are talking about it in terms of as percentage of PAT. Over the last two quarters, this increased level of uncertainty around and the volatility around free cash flow, it is a little difficult to understand. We started the year with talking about 80% OCF to PAT conversion. Last quarter, we spoke about that for the rest of the year, it would be improving, and within a quarter, it turned into negative. So, what exactly is driving this increased level of uncertainty? Is there any fundamental change in the way we are doing business by going into outcome-based model pricing and the commitments?

I am just trying to figure out that cash flow for a contractual business in a service industry should not be this volatile. It could be understandable for an industrial company, but not for a service company.

Nitin Rakesh
CEO, Mphasis

No, I understand. I understand, Rakesh. I do not think there is any structural shift, and I do not think it is linked to any outcome-based deals. I think we talked about normalized cash flow that payments spilled from 30th to 1st. Cash in transit is no longer allowed as OCF in terms of the way we do this. So, if you normalize for that, I think the cash flow is actually in the range we expected it to be. In terms of the only reason I stepped in is I do not think you should link that to any structural change or any contractual decision. Yes, there is an execution rigor that we need to continue to drive, and as Aravind said, it was disappointing to us as well that we spilled over. On the rest of the year, Aravind, you can just reiterate what you mentioned earlier.

Aravind Viswanathan
CFO, Mphasis

No, I will just make a point, right? In a contractual business, forecasting revenues are always easier than forecasting cash flows. If you look across the industry, quarterly fluctuations in cash flows by a margin are much more frequent than on revenue, right? So, hypothesis-wise, because days change cash flow significantly, revenue, for example, does not have the same volatility that cash flow has, but cash flow normalizes over a period of time. That really is what is happening here, right? So, what we have said is that we have made certain investments from a deal standpoint in last year, which is kind of playing out in FY 2027 also, and that is why we have seen a little bit of reduction in our cash flow conversions from historic levels. Our commentary is such that, I think for FY 2028, we will go back to our historic levels of cash flow generation.

I do not think volatility is uncommon in cash flow, even in IT services, but I think from a year basis, you will not see that kind of volatility. Frankly, this quarter was very, very extreme situation we have not seen very often of almost $39 million initiated on 30th, some challenge which is coming with value date of 30th, but hitting our bank account on 1st. That is actually a pretty anomaly event, right? So, it will not happen very often or often at all.

Kumar Rakesh
Analyst, BNP Paribas Mutual Fund

Got that. But even for the full year, it looks like there would be a sharp decoupling between what your top-line growth would be and what your OCF or FCF growth would be. So, I am just trying to understand that going forward as well, while we are accelerating our growth, and which has been quite remarkable in the last four quarters, we are starting to see on the margin in the last couple of quarters that has come down to the lower end of our guidance range, and that is understandable. All the companies are making investment, and we should be doing that at this point. But the impact on cash flow and not having full visibility on where it ends for the full year, it just makes me a little worried is that how we are looking at converting all the growth that we are generating into cash.

Nitin Rakesh
CEO, Mphasis

Yeah. Again, I think, Rakesh, I will just repeat what I was saying. Aravind gave you a good roadmap and path out. Let us just continue to follow that path over the next two quarters and FY 2028. So, I think as we normalize it to normal levels in 2028, none of this will be a concern because we are not worried about it.

Kumar Rakesh
Analyst, BNP Paribas Mutual Fund

That's good. Thanks, Rakesh.

Nitin Rakesh
CEO, Mphasis

Thank you.

Operator

Thank you very much. Ladies and gentlemen, we'll take that as the last question. I'll now hand the conference over to Mr. Nitin Rakesh for closing comments.

Nitin Rakesh
CEO, Mphasis

Thank you, Nirav. Let me close with what I said last quarter. We are not in the business of chasing AI trend cycles. We are building the capability that makes AI adoption at scale real for large enterprises. Tria-led business modernization and business reimagination are now clearly emerging as themes that drive pipeline and wins, unlocking budgets beyond the technology function and widening the set of problems we can solve for clients. We organized our people and our offerings to deliver that at scale, and today's guidance reflects our confidence in it. Thank you all for joining the call today. Just ahead of Dhanteras and Diwali, wishing you, your teams, and your families a joyful Diwali and steady growth in the year ahead. We are grateful for your trust and continued association and look forward to growing together in the years ahead.

Operator

Thank you very much. On behalf of Mphasis Limited, that concludes this conference. If you have any further questions, please reach out to the Mphasis Investor Relations at investor.relations@mphasis.com. Thank you for joining us, and you may now disconnect your lines. Thank you.